JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
AlphaLISA SureFire Ultra Human Total MSH3 Detection Kit, 10,000 Assay Points
AlphaLISA SureFire Ultra Human Total MSH3 Detection Kit, 10,000 Assay Points
AlphaLISA Surefire Ultra Total Protein
The AlphaLISA™ SureFire® Ultra™ Human Total MSH3 assay is a sandwich immunoassay for quantitative detection of total MSH3 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human Total MSH3 assay is a sandwich immunoassay for quantitative detection of total MSH3 in cellular lysates using Alpha Technology.
Product variants
Unit Size: 100 assay points
Part #:
ALSU-TMSH3-A-HV
Unit Size: 500 assay points
Part #:
ALSU-TMSH3-A500
Unit Size: 10,000 assay points
Part #:
ALSU-TMSH3-A10K
Unit Size: 50,000 assay points
Part #:
ALSU-TMSH3-A50K
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
AlphaLISA SureFire Ultra Human Total MSH3 Detection Kit, 10,000 Assay Points
AlphaLISA Surefire Ultra Total Protein
AlphaLISA SureFire Ultra Human Total MSH3 Detection Kit, 10,000 Assay Points
Product information
Overview
MutS Homolog 3 (MSH3) is a DNA mismatch repair protein that forms the MutSβ complex with MSH2 to recognize and repair insertion-deletion loops (IDLs) and larger mismatches in DNA. MSH3 is particularly important for repairing slipped-strand intermediates that arise during DNA replication in repetitive sequences, including microsatellites. The MutSβ complex initiates repair by recruiting MLH1-PMS2 (MutLα) and other downstream factors to excise and resynthesize the error-containing DNA strand. Deficiency in MSH3 leads to microsatellite instability (MSI) and increased mutation rates, particularly in repetitive sequences. MSH3 mutations are associated with certain hereditary cancer syndromes and contribute to tumorigenesis through genomic instability. In cancer therapy, MSH3 status influences response to DNA-damaging agents and immunotherapy, as MSI tumors often exhibit enhanced immunogenicity.
The AlphaLISA SureFire Ultra Human Total MSH3 is a sandwich immunoassay for the quantitative detection of total MSH3 in cellular lysates, using Alpha Technology.
Formats:
- The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
- The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
- The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
- The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.
AlphaLISA SureFire Ultra kits are compatible with:
- Cell and tissue lysates
- Antibody modulators
- Biotherapeutic antibodies
AlphaLISA SureFire Ultra kits can be used for:
- Cellular kinase assays
- Receptor activation studies
- High-throughput screening for preclinical studies
How it works
Total-AlphaLISA SureFire Ultra assay principle
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
Total-AlphaLISA SureFire Ultra two-plate assay protocol
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Total-AlphaLISA SureFire Ultra one-plate assay protocol
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
Assay specificity/selectivity
Knockout validation of MSH3 Total assay
MSH3 levels were assessed in A549 wild type (WT) and A549 KO (Abcam, ab288875) cell lines cultured to confluency in T175 flasks at 37°C, 5% CO2.
Each flask was lysed in 2 mL of Lysis Buffer for 10 minutes at RT with shaking. Lysates were serially diluted in Lysis Buffer and MSH3 levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
MSH3 was detected in WT but not in the KO cells. This confirms the specificity of the assay for the detection of MSH3 protein.
Assay versatility
Endogenous MSH3 expression in various cell lines
Adherent cells were seeded at 40,000 cells/well in a 96-well culture plate in complete medium and incubated overnight at 37°C, 5% CO2. Cells were lysed with 100 µL of Lysis Buffer. Suspension cells were washed with HBSS and lysed with Lysis Buffer at 4 x 106 cells/mL.
MSH3 levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate (4,000 adherent cells or 40,000 suspension cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Endogenous levels of MSH3 were detected in various cell types.
Specifications
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
MSH3
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
|
| Technology |
Alpha
|
| Therapeutic Area |
Neuroscience
Oncology
|
| Unit Size |
10,000 assay points
|
Resources
Are you looking for resources, click on the resource type to explore further.
Brochure
Alpha assays and reagents catalog
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
How can we help you?
We are here to answer your questions.
